Our multidisciplinary care team of NCIS clinicians, with our nurses, allied health professionals and other healthcare experts work together, to provide a comprehensive yet personalised care treatment plan for each and every patient's condition.
The Haematology-Oncology Research Group (HORG) is the research arm of the NCIS. The HORG comprises haematologists and oncologists committed to the research of cancers endemic to Asia, with a special interest in the development of novel drugs for cancer treatment as well as improve existing treatments.
On 14–15 March 2026, Team NCIS took part in Relay For Life at the National Stadium, joining the overnight movement in support of patients and families affected by cancer. With our largest contingent of 128 runners, staff across departments came together over 12 hours through the night, reflecting our shared commitment to care beyond the clinic.
From flag-off to sunrise, our runners kept the track moving, covering a total of 165.2km — surpassing last year’s distance despite a later start time. This collective effort placed Team NCIS 8th overall, a testament to the teamwork, resilience, and spirit demonstrated across all shifts.
Beyond the track, Team NCIS raised a total of $13,160 in support of the run. We thank all runners, supporters, and donors for being part of this meaningful cause and for carrying forward the NCIS commitment to stand with our patients at every step of their journey.
On 10 April 2026, NCIS celebrated the launch of Clinical Management of Bone and Soft Tissue Tumours, a multidisciplinary handbook developed to support the education and clinical management of sarcoma patients.
The event brought together clinicians, collaborators, patients, and distinguished guests in a strong show of support for advancing sarcoma care. The launch highlighted the collective expertise, dedication, and collaboration of healthcare professionals across Singapore and the region.
More than a publication, this handbook serves as a practical resource to strengthen multidisciplinary care, education, and clinical practice in sarcoma management. It reflects NCIS' ongoing commitment to improving cancer outcomes through clinical excellence, research, and knowledge sharing.
We thank all contributors, partners, and guests for supporting this important milestone and look forward to continuing our efforts to advance sarcoma care in Singapore and beyond.
-(2).png?sfvrsn=babc5af8_1)
-(2).png?sfvrsn=58f203f_1)
-(1).png?sfvrsn=f91454fe_1)
.png?sfvrsn=34509625_1)
.png?sfvrsn=f2c42492_1)
.png?sfvrsn=87c1dfdf_1)
.png?sfvrsn=85f60fdb_1)
.png?sfvrsn=2e27ac69_1)
.png?sfvrsn=2a353077_1)
.png?sfvrsn=3b682ccd_1)
![Mar 2026 [A5 Brochure] Radiation Therapy RT at NCIS (Version 2)](/images/ncislibraries/brochures-image/mar-2026-a5-brochure-radiation-therapy-rt-at-ncis-(version-2).png?sfvrsn=2e5cf30f_1)
